Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emmessar Biotech & Nutrition has informed that a meeting of Board of Directors of the Company, will be held on Saturday, May 21, 2022, at 11.30 am, to consider and approve the Audited Financial Results of the Company, for the Fourth Quarter / Year ended March 31, 2022. Further, Trading Window for dealing in Securities of the Company shall remain closed from April 01, 2022 till expiry of 48 hours after declaration of Audited Financial Results to BSE, as intimated earlier vide its intimation letter dated 31st March, 2022.
The above information is a part of company’s filings submitted to BSE.
